Latest Regulatory Approval News

PYC Therapeutics reports positive safety outcomes from the initial phase of its clinical trial for PYC-003, a promising treatment for Polycystic Kidney Disease. The drug was well tolerated in healthy volunteers, paving the way for patient dosing and further trials.

Peter Warren Automotive Holdings is set to acquire Wakeling Automotive, adding 16 brands and 30 dealerships to its portfolio and boosting its presence in the fast-growing Western Sydney market.

RPMGlobal shareholders convened on 19 December 2025 to vote on Caterpillar's $5.00 per share acquisition proposal, with strong board support and regulatory hurdles nearing resolution.

South Harz Potash Limited has lodged three exploration permit applications for the Torsby West Project in Sweden, securing a 25km corridor rich in copper-gold-cobalt mineralisation. This move complements their existing Glava assets and positions the company strongly in a highly prospective Scandinavian IOCG district.

GBM Resources has partially completed its $8 million placement to Wise Walkers but faces delays in receiving the remaining funds due to Chinese foreign exchange controls. Shareholder approval for the balance is now pending.

Legacy Iron Ore has ceased mining operations at Mt Celia, marking the end of Phase I, while advancing heap leach studies and exploring a Carbon-in-Leach plant to drive future growth.

Avecho Biotechnology is close to completing recruitment for the interim analysis cohort of its pivotal Phase III trial testing a CBD capsule for insomnia, with results expected in the first half of 2026.

Mount Ridley Mines has locked in nearly $1.8 million through a fully underwritten exercise of expiring unlisted options, ensuring financial backing for its Mount Ridley Project exploration and metallurgical programs.

Memphasys Limited’s partner International Technical Legacy has placed an early order for 500 Felix™ cartridges ahead of anticipated CE Mark approval, signalling strong clinic demand and validating the company’s direct-selling strategy in the Middle East.

Stellar Resources has reported a significant 51m wide tin mineralisation zone at its Severn deposit, reinforcing the potential to upgrade and expand its Heemskirk Tin Project resource. Ongoing drilling and rising tin prices underpin the company’s advancing prefeasibility study.

Perpetual Limited has extended its exclusivity agreement with Bain Capital into early 2026 as discussions continue over the potential sale of its Wealth Management business. While progress is steady, no binding deal is yet assured.

TrivarX Limited has reported compelling clinical trial results demonstrating its single-lead ECG algorithm’s high sensitivity in detecting major depressive episodes among US veterans, marking a significant step in objective mental health screening.